Clinical Trials for GI Innovation

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: GI Innovation

Clinical Trials (3)

NCT07172802
A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
76 participants
Started: Apr 22, 2025 · Completed: Sep 30, 2027
6 conditions1 sponsor3 locations
NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
PHASE1/PHASE2Recruiting
358 participants
Started: May 30, 2023 · Completed: Apr 24, 2027
9 conditions2 sponsors11 locations
NCT04977453
GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors
PHASE1/PHASE2Recruiting
430 participants
Started: Aug 2, 2021 · Completed: Dec 31, 2026
14 conditions2 sponsors8 locations